Bionovate Technologies(OTC) BIIO

Bionovate Technologies Corp is a medical device company focused on developing automated solutions for the treatment of age spots. The company aims to create a sophisticated, computer-driven system that targets and treats these blemishes effectively across various body areas.

Products and Services

• Automated systems for age spot treatment
• Targeted solutions for healthcare providers and wellness centers
• Global distribution plans for advanced medical devices

Growth Outlook

• Plans to expand product offerings in the medical device sector
• Targeting healthcare providers for increased market penetration
• Potential for global reach with innovative treatment solutions

Financial Highlights

• Recent quarterly net income of -$21,636, reflecting ongoing operational costs
• Trailing twelve months show a return on equity of 23.68%
• Current liabilities total $524,845, indicating financial obligations

Bionovate Technologies Corp operates in the medical devices industry, with a specific focus on age spot treatment solutions. The company has established a clear vision for growth, targeting healthcare providers and wellness centers for its innovative products. Despite recent financial challenges, including a negative net income, the company demonstrates potential through its return on equity and plans for global distribution. Investors may find interest in the company's commitment to developing advanced medical technologies and its strategic approach to market expansion.